226 related articles for article (PubMed ID: 26803918)
1. Hysteroscopic Patterns in Women on Treatment With Ulipristal Acetate 5 mg/day: A Preliminary Study.
Bettocchi S; Baranowski WE; Doniec J; Ceci O; Resta L; Fascilla FD; Mitola PC; Tinelli R; Cicinelli E
J Minim Invasive Gynecol; 2016; 23(5):664-9. PubMed ID: 26803918
[TBL] [Abstract][Full Text] [Related]
2. Sonographic and hysteroscopic endometrial examination in women treated with ulipristal acetate: Exploratory findings at a tertiary referral center.
Gracia M; Nonell R; Ros C; Rius M; Quintas L; Martínez-Zamora MÁ; Carmona F
Eur J Obstet Gynecol Reprod Biol; 2019 Jan; 232():40-45. PubMed ID: 30468982
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study.
De Franciscis P; Schiattarella A; Riemma G; Labriola D; Ambrosio D; Vitale SG; Cianci A; Cucinella G; Calagna G; Colacurci N
Minim Invasive Ther Allied Technol; 2022 Mar; 31(3):435-440. PubMed ID: 33043778
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy.
Ferrero S; Scala C; Vellone VG; Paudice M; Vitale SG; Cianci A; Barra F
Gynecol Obstet Invest; 2020; 85(2):178-183. PubMed ID: 31940645
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic accuracy in transvaginal echography in benign endometrial diseases and its comparison with hysteroscopic biopsy].
Persiani P; Perotti F; Riccardi A; Gallina D; Polatti F; Zara C
Minerva Ginecol; 1995 Mar; 47(3):63-7. PubMed ID: 7630511
[TBL] [Abstract][Full Text] [Related]
6. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic thickened endometrium in postmenopausal women: malignancy risk.
Famuyide AO; Breitkopf DM; Hopkins MR; Laughlin-Tommaso SK
J Minim Invasive Gynecol; 2014; 21(5):782-6. PubMed ID: 24632398
[TBL] [Abstract][Full Text] [Related]
8. Ulipristal Acetate Before High Complexity Hysteroscopic Myomectomy: A Retrospective Comparative Study.
Ferrero S; Racca A; Tafi E; Alessandri F; Venturini PL; Leone Roberti Maggiore U
J Minim Invasive Gynecol; 2016; 23(3):390-5. PubMed ID: 26707918
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopy as a valid tool for endometrial pathology in patients with postmenopausal bleeding or asymptomatic patients with a thickened endometrium: hysteroscopic and histological results.
Loiacono RM; Trojano G; Del Gaudio N; Kardhashi A; Deliso MA; Falco G; Sforza R; Laera AF; Galise I; Trojano V
Gynecol Obstet Invest; 2015; 79(3):210-6. PubMed ID: 25765014
[TBL] [Abstract][Full Text] [Related]
10. [Hysteroscopic evaluation of the uterine cavity in postmenopausal women with uterine bleeding].
Wierzbowski T; Gottwald L; Bieńkiewicz A; Suzin J
Ginekol Pol; 2003 Sep; 74(9):892-6. PubMed ID: 14674141
[TBL] [Abstract][Full Text] [Related]
11. Ulipristal Acetate Before Hysteroscopic Myomectomy: A Systematic Review.
Vitale SG; Ferrero S; Caruso S; Barra F; Marín-Buck A; Vilos GA; Vitagliano A; Török P; Ciebiera M; Cianci A
Obstet Gynecol Surv; 2020 Feb; 75(2):127-135. PubMed ID: 32105337
[TBL] [Abstract][Full Text] [Related]
12. Safety after extended repeated use of ulipristal acetate for uterine fibroids.
Fauser BC; Donnez J; Bouchard P; Barlow DH; Vázquez F; Arriagada P; Skouby SO; Palacios S; Tomaszewski J; Lemieszczuk B; William AR
PLoS One; 2017; 12(3):e0173523. PubMed ID: 28267814
[TBL] [Abstract][Full Text] [Related]
13. Ulipristal Acetate before Hysteroscopic and Laparoscopic Surgery for Uterine Myomas: Help or Hindrance?
Ferrero S; Vellone VG; Barra F; Scala C
Gynecol Obstet Invest; 2019; 84(4):313-325. PubMed ID: 30554215
[TBL] [Abstract][Full Text] [Related]
14. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium.
Whitaker LH; Murray AA; Matthews R; Shaw G; Williams AR; Saunders PT; Critchley HO
Hum Reprod; 2017 Mar; 32(3):531-543. PubMed ID: 28130434
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of Endometrial Pathologic Findings Obtained on Hysteroscopy, Transvaginal Sonography, and Gel Infusion Sonography in Women With Postmenopausal Bleeding.
Dueholm M; Hjorth IM; Secher P; Jørgensen A; Ørtoft G
J Minim Invasive Gynecol; 2015; 22(6):1036-44. PubMed ID: 26044592
[TBL] [Abstract][Full Text] [Related]
16. Comparison of transvaginal sonography, saline infusion sonography, and hysteroscopy in premenopausal women with abnormal uterine bleeding.
de Vries LD; Dijkhuizen FP; Mol BW; Brölmann HA; Moret E; Heintz AP
J Clin Ultrasound; 2000 Jun; 28(5):217-23. PubMed ID: 10799999
[TBL] [Abstract][Full Text] [Related]
17. Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
Williams AR; Bergeron C; Barlow DH; Ferenczy A
Int J Gynecol Pathol; 2012 Nov; 31(6):556-69. PubMed ID: 23018219
[TBL] [Abstract][Full Text] [Related]
18. Hysteroscopy for asymptomatic postmenopausal women with sonographically thickened endometrium.
Schmidt T; Breidenbach M; Nawroth F; Mallmann P; Beyer IM; Fleisch MC; Rein DT
Maturitas; 2009 Feb; 62(2):176-8. PubMed ID: 19121901
[TBL] [Abstract][Full Text] [Related]
19. Comparative retrospective study on transvaginal sonography versus office hysteroscopy in the diagnosis of endometrial pathology among different subgroups.
Tsonis O; Gkrozou F; Dimitriou E; Paschopoulos M
J Obstet Gynaecol Res; 2021 Feb; 47(2):669-678. PubMed ID: 33258221
[TBL] [Abstract][Full Text] [Related]
20. Transrectal ultrasound-guided hysteroscopic myomectomy of submucosal myomas with a varying degree of myometrial penetration.
Ludwin A; Ludwin I; Pityński K; Basta P; Basta A; Banas T; Jach R; Wiecheć M; Grabowska R; Stangel-Wójcikiewicz K; Milewicz T; Nocuń A
J Minim Invasive Gynecol; 2013; 20(5):672-85. PubMed ID: 23850363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
